Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time

Annals of Internal Medicine

Volumn 131, Issue 1, 1999, Pages 14-20

  Benedetti, Jacqueline K ^a,b   Zeh, Judith ^a   Corey, Lawrence ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Box 19024 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; VIRUS REACTIVATION;

EID: 0033529412     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-131-1-199907060-00004     Document Type: Article

References (33)

1. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl. 1990;69:19-36.
2. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as a serological marker of sexual lifestyle in populations. BMJ. 1994;309:1325-9.
3. Weinberg A, Canto CL, Pannuti CS, Kwang WN, Garcia SA, Zugaib M. Herpes simplex virus type 2 infection in pregnancy: asymptomatic viral excretion at delivery and seroepidemiologic survey of two socioeconomically distinct populations in Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo. 1993;35:285-90.
4. Forsgren M, Skoog E, Jeansson S, Olofsson S, Giesecke J. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS. 1994;5:113-6.
5. Bassett J, Donovan B, Bodsworth NJ, Field PR, Ho DW, Jeansson S, et al. Herpes simplex virus type 2 infection of heterosexual men attending a sexual health centre. Med J Aust. 1994;160:697-700.
6. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med. 1997;337:1105-11.
7. Oliver L, Wald A, Kim M, Zeh J, Selke S, Ashley R, et al. Seroprevalence of herpes simplex virus infections in a family medicine clinic. Arch Fam Med. 1995;4:228-32.
8. Koutsky LA, Stevens CE, Holmes KK, Ashley RL, Kiviat NB, Critchlow CW, et al. Underdiagnosis of genital herpes by current clinical and viralisolation procedures. N Engl J Med. 1992;326:1533-9.
9. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. J Infect Dis. 1996;174:470-5.
10. Corey L, Wald A. Genital herpes. In: Sexually Transmitted Diseases. Holmes KK, Mardh PA, Sparling PF, Wiesner PJ, eds. New York: McGraw-Hill: 1999:285-311.
11. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med. 1987;316:1444-9.
12. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med. 1994;121:847-54.
13. Knox SR, Corey L, Blough HA, Lerner AM. Historical findings in subjects from a high socioeconomic group who have genital infections with herpes simplex virus. Sex Transm Dis. 1982;9:15-20.
14. Catotti DN, Clarke P, Catoe K. Herpes revisited. Still a cause of concern. Sex Transm Dis. 1993;20:77-80.
15. Harger JH, Meyer MP, Amortegui AJ. Changes in the frequency of genital herpes recurrences as a function of time. Obstet Gynecol. 1986;67:637-42.
16. Fife KH, Crumpacker CS, Mertz GJ, Hill EL, Boone GS. Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir. Acyclovir Study Group. J Infect Dis. 1994;169:1338-41.
17. 1998 guidelines for the treatment of sexually transmitted diseases. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep. 1998;47:20-4.
18. Corey L, Holmes KK. Genital herpes simplex virus infection: current concepts in diagnosis, therapy, and prevention. Ann Intern Med. 1983;98:973-83.
19. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infection: clinical manifestations, course, and complications. Ann Intern Med. 1983;98:958-72.
20. Benedetti JK, Zeh J, Selke S, Corey L. Frequency and reactivation of nongenital lesions among patients with genital herpes simplex virus. Am J Med. 1995;98:237-42.
21. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subdinical and symptomatic genital herpes infections. N Engl J Med. 1995;333:770-5.
22. Ashley R. Herpes viruses: types 1 and 2. In: Laboratory Diagnosis of Viral Infections. 3d ed. Lennette EH, ed. New York: Marcel Dekker; 1998:489-513.
23. Garland SM, Lee TN, Ashley RL, Corey L, Sacks SL. Automated microneutralization: method and comparison with western blot for type-specific detection of herpes simplex antibodies in two pregnant populations. J Virol Methods. 1995;55:285-94.
24. Velleman P and Hoaglin D. Applications, Basics and Computing of Exploratory Data Analysis. Boston: Duxbury Pr; 1981.
25. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963-74.
26. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest. 1997;99:1092-7.
27. Mattison HR, Reichman RC, Benedetti J, Bolgiano D, Davis LG, Bailey-Farchione A, et al. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes. Am J Med. 1988;85:20-5.
28. Kaplowitz LG, Baker D, Gelb L, Blythe J, Hale R, Frost P, et al. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. The Acyclovir Study Group. JAMA. 1991;265:747-51.
29. Sacks SL, Aoki FY, Diaz-Mitoma F, Sellors J, Shafran SD. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group. JAMA. 1996;276:44-9.
30. Mertz GJ, Loveless MO, Levin MJ, Kraus SJ, Fowler SL, Goade D, et al. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group. Arch Intern Med. 1997;157:343-9.
31. Nilsen AE, Aasen T, Halsos AM, Kinge BR, Tjotta EA, Wikstrom K, et al. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet. 1982;2:571-3.
32. Mindel A, Faherty A, Carney O, Patou G, Freris M, Williams P. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet. 1988;1:926-8.
33. Straus SE, Takiff HE, Seidlin M, Bachrach S, Lininger L, DiGiovanna JJ, et al. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. N Engl J Med. 1984;310:1545-50.